SEC Form 4 · accession 0001104659-17-019393

SELECTA BIOSCIENCES INC · SELB

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Director

Period of report

Mar 23, 2017

Accepted (ET)

Mar 27, 2017 · 4:02 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001453687

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock	Mar 23, 2017	M	51,981	$3.44	A	179,985	D
Common Stock	Mar 23, 2017	M	8,019	$7.02	A	188,004	D
Common Stock^F1	holding	—	—		—	25,626	I	See Footnote
Common Stock^F2	holding	—	—		—	202,051	I	See Footnote

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Stock Option (right to buy)^F3	$3.44	Mar 23, 2017	M	51,981	D	—	Jan 23, 2022	Common Stock	51,981	9,932	D
Stock Option (right to buy)^F4	$7.02	Mar 23, 2017	M	8,019	D	—	Mar 8, 2026	Common Stock	8,019	17,622	D

F1These securities are held by BioDynamics Core, L.P., which is managed by BioDynamics, LLC, of which the Reporting Person is a member. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
F2These securities are held by SAF-SEL Trust, for which the Reporting Person's spouse serves as a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
F3All shares underlying this option are fully vested.
F4This option vests in 48 substantially equal monthly installments beginning on January 1, 2016.